Sort
15,842 grants matching “pancreatic cancer”
Contribution of myeloid cells to the anti-tumor adaptive immune response after radiation in a pediatric brain tumor
$238,140Mai T Dang · Washington University · K08 · FY2024 · CA
Contribution of myeloid cells to the anti-tumor adaptive immune response after radiation in a pediatric brain tumor
$238,140Mai T Dang · Washington University · K08 · FY2023 · CA
Contribution of myeloid cells to the anti-tumor adaptive immune response after radiation in a pediatric brain tumor
$238,140Mai T Dang · Washington University · K08 · FY2025 · CA
Project 2: Chemoprevention of pancreatic cancer with lipid-lowering and antidiabetic agents
$238,095Juan Enrique Rozengurt · University Of California Los Angeles · P01 · FY2023 · CA
Project 1: Adipose tissue inflammation in obesity-promoted pancreatic cancer
$238,094Guido Erwin Michael Eibl · University Of California Los Angeles · P01 · FY2023 · CA
STRAP and Smad 7 Signaling in Colerectal Carcinomas
$238,029Pran K Datta · Vanderbilt University · R01 · FY2007 · CA
Environmental Circadian Disruptors Increase Diabetes and Metabolic Disorders Risk
$237,967Margarita L Dubocovich · State University Of New York At Buffalo · R21 · FY2014 · ES
Redox-Active Agents for Pancreatic Cancer
$237,875Robert T Dorr · University Of Arizona · R01 · FY2006 · CA
Mechanism-based therapies for pancreatic cancer informed by stromal microrheology
$237,851Jonathan P Celli · University Of Massachusetts Boston · R00 · FY2015 · CA
Role of Neutrophil Extracellular Traps in Pancreatic Cancer
$237,784Brian A Boone · West Virginia University · P20 · FY2023 · GM
ONCOGENE SPECIFICITY IN ORGAN-DEFINED CANCERS
$237,770University Of Wisconsin Madison · R01 · FY2001 · CA
Brca1-Mediated Suppression Of Retrotransposon Activity - Resubmission - 1
$237,724Jef D Boeke · New York University School Of Medicine · R21 · FY2020 · CA
PANCREAS CANCER MESOTHELIN ANIMAL MODEL
$237,696Elizabeth Marion Jaffee · Johns Hopkins University · U19 · FY2007 · CA
Regulated Proteolysis in RAS Signal Transduction
$237,656Amy H. Tang · Mayo Clinic Rochester · R01 · FY2006 · GM
Method to Eliminate Pancreatic Cells with Specific Patterns of Mutations/Deletion
$237,596Daniel D Von Hoff · Translational Genomics Research Inst · P01 · FY2008 · CA
EVALUATE LAG3 AND OTHER IMMUNE MODULATORS
$237,577Drew M. Pardoll · Johns Hopkins University · U19 · FY2007 · CA
ANTITUMOR AGENTS EFFECTIVE AGAINST PANCREATIC CANCER
$237,499Harbor Branch Oceanographic Inst, Inc. · R01 · FY2005 · CA
Isolation and Purification of Cancer Stem Cells Based on Functional Appraoch
$237,407Itzhak Avital · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Purification of a Novel Antibody Against Solid Organ Cancer Stem Cells
$237,407Itzhak Avital · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Preclinical Pharmacology of the anti-Ras drug, FTS
$237,256Thyreos Corporation · R44 · FY2002 · CA
Molecular Mechanisms for Growth Factor Action of Gastrin
$237,184University Of Michigan At Ann Arbor · R01 · FY2001 · DK
PFI-TT: Point-of-Care Sensor Based on Electric Fields and Machine Learning for the Detection of Circulating MicroRNA to Identify Early Stage Pancreatic Cancer
$237,180Dharmakeerthi Nawarathna · Old Dominion University Research Foundation · · FY2022 · TIP
Microenvironmental Transport for Immunotherapy in Pancreatic Cancer
$237,169Rolf A Brekken · Methodist Hospital Research Institute · U54 · FY2019 · CA
Integrated Small Animal Imaging Research Resource
$237,149Chin-Tu Chen · University Of Chicago · P30 · FY2024 · CA
REGULATION OF PAR 4 BY ONCOGENIC RAS
$237,143University Of Kentucky · R01 · FY2000 · CA